systematic_review
    2014
    High Quality

    Coenzyme Q10 for heart failure

    Madmani ME, Yusuf Solaiman A, Tamr Agha K, Madmani Y, Shahrour Y, Essali A

    Published in Cochrane Database of Systematic Reviews

    Methodology

    Cochrane systematic review of randomized controlled trials comparing coenzyme Q10 with placebo or other therapy in patients with heart failure, assessing mortality, exercise capacity and quality of life

    Key Findings

    Included trials were small and of variable quality; evidence was insufficient to confirm or refute that coenzyme Q10 improves clinical outcomes such as exercise capacity in heart failure.

    Conclusions

    Available randomized evidence does not establish a clear benefit of coenzyme Q10 in heart failure.

    Limitations

    Small underpowered trials, heterogeneous outcome reporting, high risk of bias in several studies.

    Supplements Studied

    CoQ10
    Compound

    Coenzyme Q10, although not a primary recommended treatment, could be beneficial to patients with heart failure

    Related Health Concerns

    Study Details

    Year:2014
    Quality Score:9/10

    Disclosures

    Funding

    Cochrane Collaboration

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.